Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Lustbader

Dentist, Oral and Maxillofacial Surgery Quincy, MA Doctor of Dentistry

NPI 1447212972 CMS profile 20310

270 Quincy Ave, Quincy, MA 02169

Open in the dashboard

General payments

$54,089

117 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Lustbader of Quincy, MA is reported in the CMS Open Payments database as having received $54,089 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,108 4
2024 General $10,774 14
2023 General $14,380 21
2022 General $5,656 23
2021 General $3,354 21
2020 General $6,216 15
2019 General $3,600 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Lustbader
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to David Lustbader were reported at $10,108. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year David Lustbader Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $3,600 $142 $50–$420 $163
2020 $6,216 $96 $36–$277 $114
2021 $3,354 $138 $45–$419 $132
2022 $5,656 $144 $48–$367 $149
2023 $14,380 $153 $55–$399 $160
2024 $10,774 $152 $50–$400 $164
2025 $10,108 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Keystone Dental Inc. $32,693 53 payments
  2. Envista Holdings Corporation $10,000 1 payment
  3. Neocis Inc. $5,579 1 payment
  4. Nobel Biocare USA $4,256 42 payments
  5. Salvin Dental Specialties, Inc. $443 1 payment
  6. Kerr Corporation $210 3 payments
  7. Align Technology, Inc. $209 2 payments
  8. Southern Anesthesia & Surgical, Inc $174 1 payment
  9. Henry Schein, Inc. $161 1 payment
  10. Straumann USA LLC $138 7 payments
  11. Other $226 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $24,663 6 payments
  2. Consulting Fee $15,579 2 payments
  3. Entertainment $6,905 34 payments
  4. Food and Beverage $4,082 70 payments
  5. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $2,500 1 payment
  6. Travel and Lodging $262 2 payments
  7. Gift $98 2 payments
Products named General payments · program years 2019–2025
  1. EDUCATION $10,099 2 payments
  2. NOBELPARALLEL Dental implant $3,516 24 payments
  3. NOBELACTIVE Dental implant $3,516 24 payments
  4. NOBELACTIVE Dental implant $495 13 payments
  5. NOBELPROCERA $380 12 payments
  6. NOBELSPEEDY $380 12 payments
  7. NOBELREPLACE $247 8 payments
  8. iTero Element 5D Plus $209 2 payments
  9. NUOSS $174 1 payment
  10. NOBELPARALLEL Dental implant $133 4 payments
  11. Other $203 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

492

Median for Oral Surgery (Dentist only): 288

Drug cost

$2,656

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

0%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Fluocinonide Generic 12 $1,129
Chlorhexidine Gluconate Generic 301 $1,068
Amoxicillin Generic 143 $313
Clindamycin Hcl Generic 21 $92
Azithromycin Generic 15 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record